CY1111970T1 - Μεθοδοι για την ανιχνευση της νοσου αλτσχαϊμερ - Google Patents
Μεθοδοι για την ανιχνευση της νοσου αλτσχαϊμερInfo
- Publication number
- CY1111970T1 CY1111970T1 CY20111101024T CY111101024T CY1111970T1 CY 1111970 T1 CY1111970 T1 CY 1111970T1 CY 20111101024 T CY20111101024 T CY 20111101024T CY 111101024 T CY111101024 T CY 111101024T CY 1111970 T1 CY1111970 T1 CY 1111970T1
- Authority
- CY
- Cyprus
- Prior art keywords
- disease
- methods
- altscheimer
- detection
- alzheimer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Neurosurgery (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Μέθοδοι για τη διάγνωση ή την πρόγνωση της νόσου Αλτσχάϊμερ σε ένα άτομο. Η εν λόγω μέθοδος περιλαμβάνει τουλάχιστον ένα στάδιο ανίχνευσης της παρουσίας ή της απουσίας του πολυμορφισμού rs908832 του γονιδίου ABACA2. Η παρουσία του ελάσσονος αλληλίου του πολυμορφισμού rs908832 του γονιδίου ABACA2 υποδεικνύει ότι το υποκείμενο μπορεί να έχει προσβληθεί από τη νόσο Αλτσχάϊμερ ή ακόμη να παρουσιάζει ένα αυξημένο κίνδυνο να αναπτύξει τη νόσο Αλτσχάϊμερ.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0307501A FR2856409B1 (fr) | 2003-06-20 | 2003-06-20 | Methodes de detection de la maladie d'alzheimer |
| EP04767370A EP1639139B1 (fr) | 2003-06-20 | 2004-06-17 | Methodes de detection de la maladie d'alzheimer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1111970T1 true CY1111970T1 (el) | 2015-11-04 |
Family
ID=33484616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20111101024T CY1111970T1 (el) | 2003-06-20 | 2011-10-27 | Μεθοδοι για την ανιχνευση της νοσου αλτσχαϊμερ |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP1639139B1 (el) |
| JP (1) | JP4691491B2 (el) |
| KR (1) | KR101170651B1 (el) |
| CN (1) | CN1809645B (el) |
| AR (1) | AR044492A1 (el) |
| AT (1) | ATE518005T1 (el) |
| AU (1) | AU2004249919B2 (el) |
| BR (1) | BRPI0411658A (el) |
| CA (1) | CA2529633C (el) |
| CY (1) | CY1111970T1 (el) |
| DK (1) | DK1639139T3 (el) |
| ES (1) | ES2370491T3 (el) |
| FR (1) | FR2856409B1 (el) |
| HK (1) | HK1090392A1 (el) |
| HR (1) | HRP20110778T1 (el) |
| IL (1) | IL172690A0 (el) |
| MX (1) | MXPA05012800A (el) |
| NO (1) | NO20060257L (el) |
| PL (1) | PL1639139T3 (el) |
| PT (1) | PT1639139E (el) |
| RU (2) | RU2483108C2 (el) |
| SI (1) | SI1639139T1 (el) |
| TW (1) | TWI352738B (el) |
| WO (1) | WO2004113568A2 (el) |
| ZA (1) | ZA200509945B (el) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103013989A (zh) * | 2011-09-23 | 2013-04-03 | 深圳北京大学香港科技大学医学中心 | 与老年痴呆症发病相关的细胞周期依赖性激酶5的单核苷酸多态性位点 |
| GB201212084D0 (en) * | 2012-07-06 | 2012-08-22 | Randox Lab Ltd | Tropomyosin isoforms related to alzheimers disease and mild cognitive impairment |
| CN102768189B (zh) * | 2012-07-30 | 2014-11-19 | 黄石 | 一种药物筛选方法 |
| CN104313144B (zh) * | 2014-10-16 | 2017-02-01 | 卫生部北京医院 | 一种检测阿尔茨海默病易感性的试剂 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5853995A (en) * | 1997-01-07 | 1998-12-29 | Research Development Foundation | Large scale genotyping of diseases and a diagnostic test for spinocerebellar ataxia type 6 |
| WO2001014414A2 (en) * | 1999-08-20 | 2001-03-01 | Activepass Pharmaceuticals, Inc. | Human abc2 transporter and uses thereof |
| EP1304922A2 (en) * | 2000-07-20 | 2003-05-02 | Cephalon, Inc. | Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring |
| JP2004147502A (ja) * | 2000-07-26 | 2004-05-27 | Banyu Pharmaceut Co Ltd | ヒト及びラットａｂｃａ２遺伝子 |
| WO2002064781A2 (en) * | 2001-02-09 | 2002-08-22 | Active Pass Pharmaceuticals, Inc. | Regulation of amyloid precursor protein expression by modification of abc transporter expression or activity |
| US20050019765A1 (en) * | 2001-06-08 | 2005-01-27 | Wellington Cheryl L | Methods for treating disorders of the nervous and reproductive systems |
-
2003
- 2003-06-20 FR FR0307501A patent/FR2856409B1/fr not_active Expired - Fee Related
-
2004
- 2004-06-09 AR ARP040101994A patent/AR044492A1/es active IP Right Grant
- 2004-06-17 RU RU2009104533/10A patent/RU2483108C2/ru not_active IP Right Cessation
- 2004-06-17 PT PT04767370T patent/PT1639139E/pt unknown
- 2004-06-17 SI SI200431759T patent/SI1639139T1/sl unknown
- 2004-06-17 CN CN2004800172750A patent/CN1809645B/zh not_active Expired - Fee Related
- 2004-06-17 JP JP2006516300A patent/JP4691491B2/ja not_active Expired - Fee Related
- 2004-06-17 EP EP04767370A patent/EP1639139B1/fr not_active Expired - Lifetime
- 2004-06-17 RU RU2006101561/13A patent/RU2380423C2/ru not_active IP Right Cessation
- 2004-06-17 KR KR1020057024490A patent/KR101170651B1/ko not_active IP Right Cessation
- 2004-06-17 AU AU2004249919A patent/AU2004249919B2/en not_active Ceased
- 2004-06-17 AT AT04767370T patent/ATE518005T1/de active
- 2004-06-17 PL PL04767370T patent/PL1639139T3/pl unknown
- 2004-06-17 BR BRPI0411658-5A patent/BRPI0411658A/pt not_active IP Right Cessation
- 2004-06-17 MX MXPA05012800A patent/MXPA05012800A/es active IP Right Grant
- 2004-06-17 ES ES04767370T patent/ES2370491T3/es not_active Expired - Lifetime
- 2004-06-17 DK DK04767370.2T patent/DK1639139T3/da active
- 2004-06-17 CA CA2529633A patent/CA2529633C/fr not_active Expired - Fee Related
- 2004-06-17 WO PCT/FR2004/001509 patent/WO2004113568A2/fr active Application Filing
- 2004-06-18 TW TW093117572A patent/TWI352738B/zh not_active IP Right Cessation
-
2005
- 2005-12-07 ZA ZA200509945A patent/ZA200509945B/en unknown
- 2005-12-19 IL IL172690A patent/IL172690A0/en not_active IP Right Cessation
-
2006
- 2006-01-18 NO NO20060257A patent/NO20060257L/no not_active Application Discontinuation
- 2006-10-10 HK HK06111103.5A patent/HK1090392A1/xx not_active IP Right Cessation
-
2011
- 2011-10-26 HR HR20110778T patent/HRP20110778T1/hr unknown
- 2011-10-27 CY CY20111101024T patent/CY1111970T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE536420T1 (de) | Verbesserte verfahren für beaming | |
| CY1111970T1 (el) | Μεθοδοι για την ανιχνευση της νοσου αλτσχαϊμερ | |
| WO2004030511A3 (en) | Prostate cancer biomarkers | |
| CY1106942T1 (el) | Συστημα και μεθοδος για τη μετρηση της σχετικης θεσης ενος αντικειμενου σε σχεση με ενα σημειο αναφορας | |
| ATE473296T1 (de) | Verfahren zum nachweis abnormal methylierter nukleinsäure in heterogenen biologischen proben | |
| BRPI0607508B8 (pt) | método para detecção e/ou classificação de distúrbios proliferativos celulares colorretais ou hepatocelulares, e uso do mesmo | |
| ATE535805T1 (de) | Verfahren zur erkennung von autoantikörpern zur diagnostizierung und charakterisierung von erkrankungen | |
| MY150648A (en) | Hla alleles associated with adverse drug reactions and methods for detecting such | |
| ATE525649T1 (de) | Nachweis von proteinen mit veränderter konformation | |
| CY1117839T1 (el) | Γονιδιο τομ34 σχετιζομενο με καρκινο του παχεος εντερου | |
| BRPI0517790A (pt) | métodos e composições fluoradas para tratar doenças relacionadas à amilóide | |
| CY1118663T1 (el) | Μεθοδος αναγνωρισης κινδυνου για διαταραχη του θυρεοειδους | |
| WO2006036943A3 (en) | Determination of molecular age by detection of ink4a/arf expression | |
| ATE513280T1 (de) | Flash-erkennung | |
| EP2319939A3 (en) | Gene expression profiling of inflammatory bowel disease | |
| WO2006034879A3 (en) | Epigenetic methods and nucleic acids for the detection of lung cell proliferative disorders | |
| EA200300880A1 (ru) | Способ детекции нуклеотидного полиморфизма | |
| WO2004021010A3 (en) | Method of diagnosing colon and gastric cancers | |
| ATE317451T1 (de) | Verfahren zur diagnose, erkennung, und einstufung von dickdarmkrebs | |
| DK1853735T3 (da) | Fremgangsmåder til detektering af progressionen af cervikal dysplasi i let grad | |
| CA2531451A1 (en) | Methods and nucleic acids for analyses of colorectal cell proliferative disorders | |
| JP5000928B2 (ja) | 物体検知装置および方法 | |
| NO20053276D0 (no) | Fremgangsmate og hjelpemiddel for pavisning av mykoplasma. | |
| ATE515576T1 (de) | Protein c polymorphismen | |
| EP3315613A3 (en) | Methods and kits for diagnosing or assessing the risk of cervical cancer |